John Driscoll

Connector Assembly And Method Of Making Same

Application

#7255613 Aug 14, 2007

Filed

Sep 30, 2005

Inventor

Dennis C. Mackey (Hamilton, MA) · John J. Driscoll (Braintree, MA) · Barbara J. Byczkiewicz (Westford, MA)

Appl. No.

11/240280

Assignee

Rockwell Automation Technologies, Inc. (Mayfield, OH)

International Classification

H01R 13/514

U.S. Classification

439752, 439736

Abstract

An electrical connector, electrical connection assembly implementing at least one such electrical connector, and method of making such an electrical connector are disclosed. The method includes...

Aziridinyl Quinone Antitumor Agents

Application

#4233215 Nov 11, 1980

Filed

Oct 24, 1978

Inventor

John S. Driscoll (Rockville, MD) · A. Hameed Khan (Rockville, MD)

Appl. No.

5/954218

Assignee

United States of America (Washington, DC)

International Classification

C07D29512

U.S. Classification

260239EQ

Abstract

The use of aziridinyl quinones as antitumor agents against transplanted tumors in mice is disclosed. A compound which has been found to be particularly effective is the compound...

Method Of Determining H.sub.2 S

Application

#4780185 Oct 25, 1988

Filed

Apr 15, 1987

Inventor

John N. Driscoll (Wellesley Hills, MA) · Edwards S. Atwood (Natick, MA)

Appl. No.

7/038849

Assignee

HNU Systems, Inc. (Newton, MA)

International Classification

G01N 2730, G01N 2756

U.S. Classification

204 1T

Abstract

Gas detection electrochemical cell featuring, in one aspect, a liquid electrolyte free of any salt capable of dissociating to form in said electrolyte a weak acid or weak base (other than H. sub. 3...

Chemical Differentiating Agents

Application

#4882346 Nov 21, 1989

Filed

Jun 16, 1987

Inventor

John S. Driscoll (Rockville, MD) · Alberto Haces (Frederick, MD) · Theodore Breitman (Rockville, MD)

Appl. No.

7/062422

Assignee

The United States of America as reprsented by the Department of Health () · and Human Services (Washington, DC)

International Classification

A61K 31415

U.S. Classification

514389

Abstract

Several analogues of hexamethylene bis[acetamide] were found to be effective differentiating agents. The most effective of these compounds was 3,3'-(1,6-hexandiyl)bis[5,5-dimethyl-2,4-imidazolinedione].

Chemical Differentiating Agents

Application

#4992472 Feb 12, 1991

Filed

May 1, 1989

Inventor

John S. Driscoll (Rockville, MD) · Alberto Haces (Frederick, MD) · Theodore Breitman (Rockville, MD)

Appl. No.

7/330509

Assignee

The United States of America as represented by the Department of Health () · and Human Services (Washington, DC)

International Classification

A61K 3116, C07C23305

U.S. Classification

514616

Abstract

Several analogues of hexamethylene bis[acetamide] were found to be effective differentiating agents. The most effective of these compounds was 3,3'-(1,6-hexandiyl)bis[5,5-dimethyl-2,4-imidazolinedione].

Lipophilic, Aminohydrolase-Activated Prodrugs

Application

#5459256 Oct 17, 1995

Filed

Apr 10, 1991

Inventor

Victor E. Marquez (Gaithersburg, MD) · John S. Driscoll (Rockville, MD) · Harry Ford (Bethesda, MD) · James A. Kelley (Silver Spring, MD) · Joseph J. Barchi (Bethesda, MD) · Hiroaki Mitsuya (Rockville, MD) · Christopher K-H. Tseng (Burtonsville, MD) · David G. Johns (Bethesda, MD) · Joseph E. Tomaszewski (Rockville, MD)

Appl. No.

7/683432

Assignee

The Government of the United States of America as represented by the () · Department of Health and Human Services (Washington, DC)

International Classification

C07H 1916

U.S. Classification

536 2714

Abstract

The present invention relates, in general, to prodrugs. In particular, the present invention relates to lipophilic, aminohydrolase-activated, anti-viral nucleoside prodrug compounds, pharmaceutical...